Horizon Kinetics Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $900K | Sell |
2,759
-121
| -4% | -$39.5K | 0.01% | 187 |
|
|
2025
Q1 | $778K | Hold |
2,880
| – | – | 0.01% | 198 |
|
|
2024
Q4 | $678K | Buy |
2,880
+121
| +4% | +$28.5K | 0.01% | 214 |
|
|
2024
Q3 | $759K | Sell |
2,759
-121
| -4% | -$33.3K | 0.01% | 205 |
|
|
2024
Q2 | $700K | Hold |
2,880
| – | – | 0.01% | 193 |
|
|
2024
Q1 | $430K | Hold |
2,880
| – | – | 0.01% | 220 |
|
|
2023
Q4 | $551K | Sell |
2,880
-120
| -4% | -$23K | 0.01% | 206 |
|
|
2023
Q3 | $531K | Hold |
3,000
| – | – | 0.01% | 206 |
|
|
2023
Q2 | $570K | Hold |
3,000
| – | – | 0.01% | 205 |
|
|
2023
Q1 | $601K | Hold |
3,000
| – | – | 0.01% | 198 |
|
|
2022
Q4 | $713K | Hold |
3,000
| – | – | 0.01% | 180 |
|
|
2022
Q3 | $600K | Hold |
3,000
| – | – | 0.01% | 194 |
|
|
2022
Q2 | $438K | Hold |
3,000
| – | – | 0.01% | 227 |
|
|
2022
Q1 | $490K | Hold |
3,000
| – | – | 0.01% | 233 |
|
|
2021
Q4 | $509K | Hold |
3,000
| – | – | 0.01% | 242 |
|
|
2021
Q3 | $566K | Hold |
3,000
| – | – | 0.01% | 227 |
|
|
2021
Q2 | $509K | Hold |
3,000
| – | – | 0.01% | 237 |
|
|
2021
Q1 | $424K | Hold |
3,000
| – | – | 0.01% | 243 |
|
|
2020
Q4 | $390K | Hold |
3,000
| – | – | 0.01% | 255 |
|
|
2020
Q3 | $437K | Hold |
3,000
| – | – | 0.02% | 250 |
|
|
2020
Q2 | $444K | Buy |
+3,000
| New | +$444K | 0.02% | 247 |
|